The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...
Health on MSN19h
What To Know About Chronic RhinosinusitisMedically reviewed by Jurairat J. Molina, MD Chronic rhinosinusitis is inflammation of the sinuses and nasal passages that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback